Citing increased risk of cardiac arrhythmias and a lack of therapeutic benefit associated with high doses of the selective serotonin reuptake inhibitor (SSRI) citalopram hydrobromide (Celexa), the FDA ...
High doses of the antidepressants citalopram (Celexa) and escitalopram (Cipralex, Lexapro) do not appear to carry greater risk of sudden cardiac death than comparable doses of other selective ...
The U.S. Food and Drug Administration (FDA) has reduced the maximum recommended dose of the antidepressant Celexa (citalopram) to 40 mg per day, warning that higher doses may trigger potentially fatal ...
New research finds no increased risk of abnormal heart rhythms, death despite FDA warning against high-dose citalopram dosages. The U.S. Food and Drug Administration's warning that high doses of the ...
The FDA has notified healthcare professionals and patients that Celexa (citalopram hydrobromide; Forest) should no longer be used at doses >40mg/day because it can cause arrhythmias (eg, QT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results